Figure 1.

LfcinB-P13 selectively suppresses the proliferation of SMMC7721 cells in vitro. (A) LfcinB-P13-treated SMMC7721 cells exhibited decreased viability in a dose-dependent manner 24 h post-treatment. (B) LfcinB-P13 exhibited decreased cytotoxicity in L02 cells 24 h post-treatment. (C) SMMC7721 cell viability was inhibited following treatment with LfcinB-P13 in a dose- and time-dependent manner. Values are presented as the mean ± standard deviation from three independent experiments, each with six replicates. *P<0.05, **P<0.01 vs. the untreated control group. LfcinB-P13, bovine lactoferricin P13.